First News

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The  vitamin D therapy market  is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Oral route of administration expected to fuel the growth of the vitamin D therapy market over the forecast period . By route of administration, the market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route. Increasing use of vitamin D in osteoporosis to d...

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The  vitamin D therapy market  is projected to reach  USD 3.3 billion by 2024 from USD 1.9 billion in 2019 , at a  CAGR of 11.6% . Market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route. Market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications. The osteoporosis segment is expected to register the highest growth during the fore...

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The  global vitamin D therapy market  is projected to reach $3.3 billion by 2024 from $1.9 billion in 2019, at a  CAGR  of 11.6%. Oral route of administration expected to fuel the growth of the vitamin D therapy market over the forecast period By route of administration, the market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route. Increasing use of vitamin D in osteoporosis to drive market grow...

The vitamin D therapy market is expected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.  Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The vitamin D therapy market is highly fragmented in nature, with a large number of players offering a variety of products. The major players operating in this market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India). The key growth strategies followed by most companies in the vitamin D therapy market are agreements & collaborations. These two strategies accounted for the largest...